United States RNA Sequencing Market Set to Reach USD 5.14 Billion by 2033, Driven by Rising Demand for Precision Medicine and Advancements in Genomic Research Technologies

The RNA Sequencing Market reached US$ 3,712.4 million in 2025 and is expected to reach US$ 17,148.6 million by 2033, growing at a CAGR of 22.7% during the forecast period 2026-2033. Growth is driven by increasing demand for precision medicine and advanced genomic research worldwide. Rising prevalence of cancer and genetic disorders is accelerating the adoption of RNA sequencing technologies in diagnostics and therapeutics. Advancements in next-generation sequencing platforms and bioinformatics tools are further enhancing accuracy and efficiency. Additionally, growing investments in transcriptomics research and drug discovery programs are supporting market expansion. Expanding applications in biomarker identification, disease profiling, and personalized healthcare are also contributing to strong market growth.

Download PDF Sample Report:
https://www.datamintelligence.com/download-sample/rna-sequencing-market?prasad

RNA Sequencing Market Major Players:

Roche Holding AG

Roche is a global leader in pharmaceuticals and diagnostics, with a strong presence in the RNA sequencing ecosystem through its sequencing platforms, molecular diagnostics, and precision medicine initiatives. In 2025, Roche reported revenue of USD 70.0 billion, driven by its pharmaceuticals and diagnostics divisions. In the RNA sequencing market, Roche plays a major role by offering advanced sequencing technologies, sample preparation kits, and integrated genomics solutions used in oncology, infectious disease research, and personalized medicine. Its focus on clinical genomics and precision diagnostics makes RNA sequencing a critical tool for disease profiling and therapeutic development.

Agilent Technologies, Inc.

Agilent Technologies is a leading provider of analytical instruments and life sciences solutions, with strong relevance in RNA sequencing workflows through its sample preparation and analytical platforms. In 2025, the company reported revenue of USD 7.1 billion, driven by life sciences, diagnostics, and applied markets. In the RNA sequencing market, Agilent plays a key role by supplying library preparation kits, quality control systems, and bioanalytical instruments that ensure accurate and efficient RNA sequencing processes. Its technologies are widely used in genomics research, clinical diagnostics, and pharmaceutical development.

Illumina Inc

Illumina is the global leader in next-generation sequencing (NGS) technologies and a dominant player in the RNA sequencing market. In 2025, the company reported revenue of USD 4.5 billion, driven by strong demand for sequencing platforms and genomic research tools. In the RNA sequencing market, Illumina plays a central role by providing high-throughput sequencing systems, reagents, and bioinformatics solutions that enable transcriptome analysis and gene expression profiling. Its technologies are widely used in academic research, clinical genomics, and drug discovery, making it a cornerstone of modern molecular biology and precision medicine.

Find the Right Partner to Accelerate Your Growth Today with Our Latest Report:
https://www.datamintelligence.com/partner-identification-enquiry/rna-sequencing-market?prasad

United States: Recent Developments

✅ In April 2026, Illumina expanded its RNA sequencing platforms with improved single-cell transcriptomics capabilities for cancer and immunology research. The upgrade enhances gene expression resolution and data accuracy. Illumina continues leading next-generation sequencing innovation.

✅ In March 2026, 10x Genomics advanced its RNA sequencing ecosystem with high-throughput spatial transcriptomics tools for tissue-level gene mapping. The development improves disease mechanism research. 10x Genomics continues expanding multi-omics solutions.

✅ In February 2026, Thermo Fisher Scientific enhanced its RNA sequencing workflows with faster library preparation kits and improved automation for clinical research applications. The innovation reduces sequencing turnaround time. Thermo Fisher continues strengthening genomic research infrastructure.

✅ In January 2026, Pacific Biosciences improved its long-read RNA sequencing technology with higher accuracy transcript detection for rare disease research. The upgrade enhances structural RNA analysis. PacBio continues advancing precision genomics.

Japan: Recent Developments

✅ In April 2026, Takara Bio strengthened its RNA sequencing solutions with enhanced sample preparation kits optimized for high-sensitivity transcriptomic analysis. The improvement supports cancer and genetic research applications. Takara Bio continues advancing molecular biology tools.

✅ In March 2026, RIKEN Institute expanded its genomic research capabilities with upgraded RNA sequencing platforms for large-scale population genomics studies. The development improves biological data integration. RIKEN continues leading national genomics research initiatives.

✅ In February 2026, Shimadzu Corporation enhanced its RNA sequencing analytical instruments with improved accuracy in nucleic acid quantification and sequencing validation. The upgrade supports pharmaceutical and clinical research. Shimadzu continues advancing bioanalytical technologies.

✅ In January 2026, Fujitsu Laboratories improved its AI-driven RNA sequencing data analysis platform with enhanced pattern recognition for gene expression studies. The development accelerates genomic interpretation workflows. Fujitsu continues supporting bioinformatics innovation.

Segment Covered in the RNA Sequencing Market:

By Products & Services: RNA Sequencing Services
RNA sequencing services dominate the market due to increasing outsourcing of complex genomic workflows by pharmaceutical companies, biotechnology firms, and academic institutions. These services reduce infrastructure costs while providing high-throughput sequencing, advanced bioinformatics analysis, and faster research outcomes.
RNA sequencing services account for approximately 41% of the total market. Based on a global RNA sequencing market size assumption of USD 12.6 billion in 2025, this translates to an estimated segment value of USD 5.2 billion. Growth is driven by rising demand for precision medicine, expanding genomic research, and increasing adoption of outsourced sequencing models.

By Technology: Sequencing by Synthesis (SBS)
Sequencing by synthesis (SBS) dominates the technology segment due to its high accuracy, scalability, and widespread adoption in next-generation sequencing platforms. It is extensively used in transcriptomics, gene expression analysis, and clinical research applications.
This segment accounts for approximately 45% of the total market. Based on the USD 12.6 billion market size in 2025, this corresponds to an estimated value of USD 5.7 billion. Growth is driven by continuous technological advancements, declining sequencing costs, and increasing adoption in clinical genomics.

By Application: Expression Profiling Analysis
Expression profiling analysis is the leading application segment due to its critical role in understanding gene expression patterns, disease mechanisms, and drug response pathways. It is widely used in oncology, genetic research, and biomarker discovery.
This segment accounts for approximately 38% of the total market. Based on the USD 12.6 billion global market size in 2025, this corresponds to an estimated value of USD 4.8 billion. Growth is driven by rising demand for personalized medicine and increasing use of RNA sequencing in clinical diagnostics.

By End-User: Research Centers
Research centers dominate the end-user segment due to extensive use of RNA sequencing in academic research, genomic studies, and biomedical innovation. These institutions are major contributors to transcriptomics and gene expression research.
This segment accounts for approximately 44% of the total market. Based on the USD 12.6 billion global market size in 2025, this corresponds to an estimated value of USD 5.5 billion. Growth is driven by increased government funding for genomic research and expanding collaborations with biotechnology companies.

Market Segmentation

The RNA Sequencing Market is segmented by products & services into sample preparation products, data analysis, storage & management, and RNA sequencing services; by technology into segment ion semiconductor sequencing, single molecule real time sequencing, nanopore sequencing, and sequencing by synthesis; by application into small RNA sequencing, expression profiling analysis, de novo transcriptome assembly, variant calling, and transcriptome epigenetics; by end-user into research centers, biotechnology labs, healthcare centers, and others; and by region into North America, Latin America, and Europe.

Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/rna-sequencing-market?prasad

Regional Analysis

North America
North America is the leading market due to advanced genomic research infrastructure, strong funding for life sciences, and high adoption of next-generation sequencing technologies. The region is led by the United States.
The North American market is estimated at approximately USD 5.6 billion in 2025, accounting for about 44% of the global market. Growth is driven by increasing precision medicine initiatives, strong presence of biotechnology companies, and expanding clinical genomics applications.

Europe
Europe is a significant market supported by strong academic research institutions, growing genomics initiatives, and supportive government funding for life sciences innovation. Key contributors include Germany, France, and the United Kingdom.
The European market is valued at approximately USD 4.3 billion in 2025, representing about 34% of the global market. Growth is driven by expanding biomedical research programs, increasing adoption of precision medicine, and rising clinical applications of RNA sequencing.

Latin America
Latin America is an emerging market driven by growing investments in biotechnology research, improving healthcare infrastructure, and increasing adoption of genomic technologies, with Brazil and Mexico as key contributors.
The market is estimated at approximately USD 2.7 billion in 2025, accounting for about 22% of the global market. Growth is supported by expanding research collaborations and increasing focus on molecular diagnostics.

Data-Driven Research Methodology for the RNA Sequencing Market:

Our research process for the RNA Sequencing Market at DataM Intelligence combines rigorous primary and secondary research to ensure accurate and reliable insights. We engage with industry experts, key stakeholders, and validated data sources to capture real-time market dynamics. Advanced analytical tools and proprietary models are applied to forecast trends, competitive landscapes, and growth opportunities. Each report undergoes multi-level validation to deliver actionable intelligence that supports strategic decision-making.

Unlock Full 360° Strategic Report:
https://www.datamintelligence.com/buy-now-page?report=rna-sequencing-market?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Contact Us-
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us
DataM Intelligence is a market research and consulting firm that delivers comprehensive end-to-end business solutions, covering everything from in-depth research to strategic consulting. The company leverages key industry trends, insights, and developments to provide fast, reliable, and actionable solutions tailored to diverse client requirements.
It offers both syndicated and customized research reports supported by a strong and robust methodology. With an extensive database comprising 9000+ reports across 40+ industry domains, DataM Intelligence serves over 200 companies in more than 50 countries, helping organizations access critical business intelligence that drives informed decision-making and sustainable growth.

This release was published on openPR.